← Eichor
Study identifier: NCT05122078 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Analgesia Nociception Index (ANI)-Guided Analgesia on Postoperative Bowel Function.

Condition: Postoperative Bowel Function Recovery  ·  Sponsor: Gangnam Severance Hospital

PhaseNA
Planned participants80
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

Investigators will examaine the effects of Analgesia Nociception Index (ANI)-guided analgesia on postoperative bowel function recovery in laparoscopic colorectal surgery. This is a prospective randomized-controlled study. Investigators will randomly divide the patients into two groups. In ANI group, remifentanil infusion rate during anesthesia will be adjusted according to ANI monitoring. In Control group, remifentanil infusion rate during anesthesia will be adjusted according to the conventional method of blood pressure and heart rate monitroing. And Investigators will evalualte the bowel function recovery in both groups after surgery, and compare between the two groups.

This description comes directly from the study's public registry record.

Talk to the study team

Young Song  ·  82-2-2019-3520  ·  NEARMYHEART@yuhs.ac

Myung IL Bae  ·  82-2-2019-3520  ·  BMI87@yuhs.ac

Always discuss trial participation with your own doctor first.

Locations (1)

GangnamSeverance HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05122078